Decheng Capital Management III (Cayman)’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $15.6M | Hold |
869,790
| – | – | 5.21% | 6 |
|
|
2023
Q2 | $17.7M | Hold |
869,790
| – | – | 5.54% | 6 |
|
|
2023
Q1 | $15.9M | Hold |
869,790
| – | – | 6.4% | 8 |
|
|
2022
Q4 | $18M | Hold |
869,790
| – | – | 6.73% | 5 |
|
|
2022
Q3 | $22.8M | Hold |
869,790
| – | – | 8.25% | 5 |
|
|
2022
Q2 | $22M | Hold |
869,790
| – | – | 8.36% | 5 |
|
|
2022
Q1 | $27.5M | Buy |
+869,790
| New | +$27.5M | 8.41% | 4 |
|